About

Dr. Waltmann is a scientist trained in molecular epidemiology and genomics of infectious diseases. Her long-term career goal is to improve the reproductive and sexual health of individuals at risk of sexually-transmitted infections, especially those at risk of gonorrhea with a focus on vulnerable or understudied populations, such as women, expectant mothers, and HIV-positive persons. She strives to conduct thoughtfully designed observational studies to better understand risk factors for STIs and to advance knowledge of gonorrhea immunology by deploying cutting-edge, multi-omic approaches (genomics and transcriptomics) directly on patient samples exposed to gonorrhea and STIs. Waltmann ultimately wants her work to contribute to the improvement of health outcomes in those most at risk of STIs and the licensure of a gonorrhea vaccine.

In the news

• 

  Protection Against N. Gonorrhoeae Induced by OMV-Based Meningococcal Vaccines are Associated with Cross-Species Directed Humoral and Cellular Immune Responses

  Recent studies in humans and mice have found that meningococcal outer membrane vesicle-containing vaccines (OMV) induce cross-species immune responses against gonococci and are associated with protection. To study this, Andreea Waltmann, PhD, immunized mice with two meningococcal OMV-containing vaccines known to accelerate clearance of N. gonorrhoeae, 4CMenB and OMV from an engineered N. meningitidis strain lacking … Read more

• 

  Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

  Recently published in eBioMedicine, this study represents the work of the late Professor Steve Meshnick who served as mentor to Andreea Waltmann, a postdoctoral scholar with the Institute for Global Health & Infectious Diseases. Dr. Meshnick died August 5, 2020.  Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination … Read more

Education